Primum non nocere: balancing allogeneic and autologous transfusion risks with a 'society perspective'.
Rebulla
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D016470:Bacteremia / Q000635:transmission; D001803:Blood Transfusion; D001804:Blood Transfusion, Autologous / Q000009:adverse effects; D001943:Breast Neoplasms / Q000628:therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009360:Neoplastic Cells, Circulating; D017713:Platelet Transfusion; D010983:Plateletpheresis / Q000009:adverse effects; D011639:Public Opinion; D018570:Risk Assessment; D012449:Safety; D013921:Thrombocytopenia / Q000139:chemically induced / Q000628:therapy; D065227:Transfusion Reaction